644 results on '"Lee, Stanley"'
Search Results
2. Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
3. An Open-Source, Vender Agnostic Hardware and Software Pipeline for Integration of Artificial Intelligence in Radiology Workflow.
4. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
5. Table S2 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
6. Figure S1-S8 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
7. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression
8. R-loop accumulation in spliceosome mutant leukemias confers sensitivity to PARP1 inhibition by triggering transcription-replication conflicts
9. 1399 Identification of alternative splicing-derived targets for TCR-T cell therapies
10. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia
11. E-cigarette or vaping product use-associated lung injury in the pediatric population: imaging features at presentation and short-term follow-up
12. DNA methylation disruption reshapes the hematopoietic differentiation landscape
13. AVAPS USE IN TRACHEOSTOMY-DEPENDENT INFANTS WITH BRONCHOPULMONARY DYSPLASIA
14. FTP6.12 The Quality of Service & “Negative Appendicectomy” Rate in a Rural General Hospital between 2013 and 2022
15. FTP6.11 The Quality of Service of Emergency Appendicectomy in Children in a Rural General Hospital between 2013 and 2022
16. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
17. Spliceosomal disruption of the non-canonical BAF complex in cancer
18. Therapeutic Targeting of RNA Splicing in Cancer
19. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
20. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
21. How do the attributes and changes of senior management affect the company’s abnormal rate of return? Evidence from China
22. Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
23. Abstract 6183: PARP inhibitors preferentially sensitize splicing factor mutant myeloid neoplasms
24. Data from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
25. Table S5 from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
26. Data from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
27. Supplementary Figures from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
28. Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
29. Supplementary Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
30. Supplementary Methods from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
31. Supplementary Methods, Figures 1 - 5, Tables 1 - 5 from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
32. Supplementary Table Captions from Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis
33. Data from Epigenetic Regulator Smchd1 Functions as a Tumor Suppressor
34. Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
35. ROBUST HYPERPARAMETER ESTIMATION PROTECTS AGAINST HYPERVARIABLE GENES AND IMPROVES POWER TO DETECT DIFFERENTIAL EXPRESSION
36. Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2
37. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development
38. Protein biomarkers for response to XPO1 inhibition in hematologic malignancies
39. Therapeutic Targeting of Spliceosome Mutant Myeloid Neoplasms Via PARP1 Inhibition
40. A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation
41. A non‐canonical function of Ezh2 preserves immune homeostasis
42. Atypical pulmonary carcinoid tumor encapsulated by a Staphylococcus aureus infection
43. Therapeutic targeting of splicing in cancer
44. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
45. Atypical Pulmonary Carcinoid Tumor Encapsulated in a Staphylococcus aureus Infection
46. Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma
47. Spliceosome Mutant Myeloid Malignancies Are Preferentially Sensitive to PARP Inhibition
48. The mutational landscape of paroxysmal nocturnal hemoglobinuria revealed: new insights into clonal dominance
49. Faith in the Land of Make-Believe
50. DEAD-Box RNA Helicases and Genome Stability
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.